In English | En español
Questions About Cancer? 1-800-4-CANCER

What You Need To Know About™

Prostate Cancer

  • Posted: 09/26/2012

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF
  • Download to Kindle
  • Download to other E-readers
  • Order Free Copy

Cancer Treatment Research

Cancer research has led to real progress in prostate cancer detection, treatment, and supportive care. Because of research, men with prostate cancer can look forward to a better quality of life and less chance of dying from the disease. Continuing research offers hope that, in the future, even more men with this disease will be treated successfully.

Doctors continue to search for new and better ways to treat prostate cancer. All over the world, doctors are conducting many types of cancer treatment research studies (clinical trials).

NCI is sponsoring many studies with men who have prostate cancer, such as studies of chemotherapy, hormone therapy, radiation therapy, and their combinations.

Even if a man who takes part in a clinical trial doesn’t benefit directly from the treatment under study, he may still make an important contribution by helping doctors learn more about prostate cancer and how to control it. Although clinical trials may pose some risks, researchers do all they can to protect their patients.

If you’re interested in being part of a clinical trial, talk with your doctor. You may want to read the NCI booklet Taking Part in Cancer Treatment Research Studies. It describes how treatment studies are carried out and explains their possible benefits and risks.

NCI’s website has a section on research studies at http://www.cancer.gov/clinicaltrials. It has general information about clinical trials as well as detailed information about specific ongoing studies of prostate cancer. Check for treatment research studies for prostate cancer that are now accepting patients.

NCI’s Cancer Information Service can answer your questions and provide information about clinical trials. Contact CIS at 1-800-4-CANCER (1-800-422-6237) or at LiveHelp (https://livehelp.cancer.gov).

This text may be reproduced or reused freely. Please credit the National Cancer Institute as the source. Any graphics may be owned by the artist or publisher who created them, and permission may be needed for their reuse.